$XBIT
XBiotech Inc

2021 Q4 Form 10-K Financial Statement

#000117184322001904 Filed on March 15, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2021 Q2
Revenue $4.500M $4.500M $4.525M
YoY Change -14.61% -57.34% -70.8%
Cost Of Revenue $1.046M $1.110M $1.360M
YoY Change -53.51% -88.22% -89.7%
Gross Profit $3.454M $3.409M $3.165M
YoY Change 14.37% 203.56% 37.79%
Gross Profit Margin 76.76% 75.76% 69.94%
Selling, General & Admin $1.866M $1.541M $4.516M
YoY Change -58.35% -55.33% -27.74%
% of Gross Profit 54.02% 45.2% 142.69%
Research & Development $8.782M $5.599M $9.254M
YoY Change 153.82% 138.66% 260.78%
% of Gross Profit 254.26% 164.24% 292.39%
Depreciation & Amortization $702.0K $687.0K $639.0K
YoY Change 18.98% 24.91% 18.33%
% of Gross Profit 20.32% 20.15% 20.19%
Operating Expenses $10.65M $7.139M $13.77M
YoY Change 34.11% 23.23% 56.28%
Operating Profit -$7.193M -$3.731M -$10.61M
YoY Change 46.14% -20.11% 62.8%
Interest Expense -$474.0K -$1.203M $916.0K
YoY Change -116.75% -181.28% -672.5%
% of Operating Profit
Other Income/Expense, Net $0.00 -$1.324M $914.0K
YoY Change -189.7% -238.07%
Pretax Income -$7.668M -$5.055M -$9.691M
YoY Change 266.89% 58.27% 35.05%
Income Tax -$1.201M -$1.800M -$4.570M
% Of Pretax Income
Net Earnings -$6.467M -$3.261M -$5.118M
YoY Change 251.85% 29.1% -25.22%
Net Earnings / Revenue -143.71% -72.47% -113.1%
Basic Earnings Per Share -$0.21 -$0.11 -$0.17
Diluted Earnings Per Share -$212.7K -$107.5K -$170.7K
COMMON SHARES
Basic Shares Outstanding 30.40M 30.38M 29.98M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 Q3 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $237.0M $238.9M $315.3M
YoY Change -0.18% 0.2% 37.25%
Cash & Equivalents $237.0M $238.9M $315.3M
Short-Term Investments
Other Short-Term Assets $934.0K $919.0K $1.471M
YoY Change -66.64% -8.1% -50.97%
Inventory
Prepaid Expenses
Receivables $0.00 $44.00K $25.00K
Other Receivables $8.953M $10.40M $8.109M
Total Short-Term Assets $246.9M $250.2M $324.9M
YoY Change -24.24% -0.58% 25.73%
LONG-TERM ASSETS
Property, Plant & Equipment $28.31M $28.64M $28.45M
YoY Change 3.55% 9.28% 14.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $642.0K $642.0K
YoY Change -100.0% 60.5% 60.5%
Total Long-Term Assets $28.31M $29.28M $29.09M
YoY Change 1.57% -71.21% -71.02%
TOTAL ASSETS
Total Short-Term Assets $246.9M $250.2M $324.9M
Total Long-Term Assets $28.31M $29.28M $29.09M
Total Assets $275.2M $279.5M $354.0M
YoY Change -22.21% -20.9% -1.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.069M $1.012M $1.491M
YoY Change -16.94% -73.85% -71.55%
Accrued Expenses $1.374M $1.643M $1.681M
YoY Change 1.7% -28.75% -65.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.453M $3.861M $3.891M
YoY Change -13.33% -37.71% -72.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.466M $1.393M $1.393M
YoY Change 33.27% 26.64% 26.64%
Total Long-Term Liabilities $1.466M $1.393M $1.393M
YoY Change 33.27% 26.64% 26.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.453M $3.861M $3.891M
Total Long-Term Liabilities $1.466M $1.393M $1.393M
Total Liabilities $5.792M $5.362M $5.392M
YoY Change 13.46% -26.08% -64.51%
SHAREHOLDERS EQUITY
Retained Earnings $5.151M $11.62M $89.88M
YoY Change -94.72% -87.74% -7.64%
Common Stock $262.3M $260.9M $256.8M
YoY Change 4.99% 3.61% 4.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $269.4M $274.2M $348.6M
YoY Change
Total Liabilities & Shareholders Equity $275.2M $279.5M $354.0M
YoY Change -22.21% -20.9% -1.34%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2021 Q2
OPERATING ACTIVITIES
Net Income -$6.467M -$3.261M -$5.118M
YoY Change 251.85% 29.1% -25.22%
Depreciation, Depletion And Amortization $702.0K $687.0K $639.0K
YoY Change 18.98% 24.91% 18.33%
Cash From Operating Activities -$1.759M -$3.402M $72.80M
YoY Change 351.03% -145.48% -729.18%
INVESTING ACTIVITIES
Capital Expenditures -$476.0K -$700.0K -$1.709M
YoY Change -78.56% 1.45% 297.44%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$476.0K -$700.0K -$1.709M
YoY Change -78.56% 1.45% 297.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 33.00K -72.04M 3.978M
YoY Change -122.0% -3330.45% 1320.71%
NET CHANGE
Cash From Operating Activities -1.759M -3.402M 72.80M
Cash From Investing Activities -476.0K -700.0K -1.709M
Cash From Financing Activities 33.00K -72.04M 3.978M
Net Change In Cash -2.202M -76.14M 75.06M
YoY Change -20.22% -944.14% -740.49%
FREE CASH FLOW
Cash From Operating Activities -$1.759M -$3.402M $72.80M
Capital Expenditures -$476.0K -$700.0K -$1.709M
Free Cash Flow -$1.283M -$2.702M $74.50M
YoY Change -170.11% -133.07% -768.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
262263000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
249805000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1971000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
237366000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27336000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 USD
CY2021 dei Auditor Location
AuditorLocation
Austin, Texas
CY2021Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2020Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2021 us-gaap Preferred Stock Shares Authorized Unlimited
PreferredStockSharesAuthorizedUnlimited
Unlimited
CY2020 us-gaap Preferred Stock Shares Authorized Unlimited
PreferredStockSharesAuthorizedUnlimited
Unlimited
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2020 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30439275
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29304396
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
275177000 USD
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8044000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
236983000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4113000 USD
CY2021Q4 xbit Escrow Receivable Current
EscrowReceivableCurrent
0 USD
CY2020Q4 xbit Escrow Receivable Current
EscrowReceivableCurrent
75063000 USD
CY2021Q4 xbit Deferred Cost Of Goods Sold
DeferredCostOfGoodsSold
0 USD
CY2020Q4 xbit Deferred Cost Of Goods Sold
DeferredCostOfGoodsSold
2177000 USD
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
8953000 USD
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
6574000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
934000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
582000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
246870000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
325875000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
533000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28307000 USD
CY2021Q4 us-gaap Assets
Assets
275177000 USD
CY2020Q4 us-gaap Assets
Assets
353744000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2069000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2491000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1374000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1351000 USD
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
10000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
142000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3453000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3984000 USD
CY2021Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1466000 USD
CY2020Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1121000 USD
CY2019 xbit Amount Held In Escrow
AmountHeldInEscrow
-75000000 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
352000 USD
CY2021 xbit Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
-533000 USD
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30823458
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
873000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1266000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5151000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
5792000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
5105000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-503000 USD
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
17.17
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30043380
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
97568000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
269385000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
348639000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
353744000 USD
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
18394000 USD
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
43997000 USD
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 USD
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5820000 USD
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
34548000 USD
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 USD
CY2021 us-gaap Gross Profit
GrossProfit
12574000 USD
CY2020 us-gaap Gross Profit
GrossProfit
9449000 USD
CY2019 us-gaap Gross Profit
GrossProfit
0 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28268000 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9527000 USD
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24090000 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9388000 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18198000 USD
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7143000 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
37656000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
27725000 USD
CY2019 us-gaap Operating Expenses
OperatingExpenses
31233000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-25082000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-18276000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-31233000 USD
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
467000 USD
CY2020 us-gaap Investment Income Net
InvestmentIncomeNet
2456000 USD
CY2019 us-gaap Investment Income Net
InvestmentIncomeNet
564000 USD
CY2021 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 USD
CY2020 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 USD
CY2019 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
750000000 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-132000 USD
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10000 USD
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-711000 USD
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3496000 USD
CY2019 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-888000 USD
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-376000 USD
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5449000 USD
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
749686000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25458000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12827000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
718453000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8044000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1606000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49824000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-17414000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-11221000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
668629000 USD
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38945468
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16709000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9849000 USD
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
668778000 USD
CY2019 xbit Gain Loss On Disposition Of Assets Excluding Escrow Receivable
GainLossOnDispositionOfAssetsExcludingEscrowReceivable
675000000 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4113000 USD
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
14.44
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30043380
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30823458
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46319457
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-17414000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-11221000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
668629000 USD
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
705000 USD
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1372000 USD
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
149000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
41398000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
668629000 USD
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
149000 USD
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38062000 USD
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3835000 USD
CY2019 xbit Common Stock Share Subscribed Value Issuance
CommonStockShareSubscribedValueIssuance
-102000 USD
CY2019 xbit Adjustments To Additional Paid In Capital Collection Of Stock Subscription Receivable
AdjustmentsToAdditionalPaidInCapitalCollectionOfStockSubscriptionReceivable
302000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3358000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
755631000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-11221000 USD
CY2020 xbit Shares Buyback Equity Impact Amount
SharesBuybackEquityImpactAmount
-420000000 USD
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1372000 USD
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10276000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12581000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
348639000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-17414000 USD
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
705000 USD
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7995000 USD
CY2021 us-gaap Dividends Common Stock
DividendsCommonStock
75003000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4463000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
269385000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-17414000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-11221000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
668629000 USD
CY2021 us-gaap Depreciation
Depreciation
2648000 USD
CY2020 us-gaap Depreciation
Depreciation
2238000 USD
CY2019 us-gaap Depreciation
Depreciation
2361000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
4463000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
12581000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
3358000 USD
CY2021 xbit Gain Loss On Disposition Of Assets Excluding Escrow Receivable
GainLossOnDispositionOfAssetsExcludingEscrowReceivable
-0 USD
CY2020 xbit Gain Loss On Disposition Of Assets Excluding Escrow Receivable
GainLossOnDispositionOfAssetsExcludingEscrowReceivable
-0 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4113000 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-0 USD
CY2021 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
2380000 USD
CY2020 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
6574000 USD
CY2019 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-0 USD
CY2021 xbit Increase Decrease In Deferred Cost Of Goods Sold
IncreaseDecreaseInDeferredCostOfGoodsSold
-2177000 USD
CY2020 xbit Increase Decrease In Deferred Cost Of Goods Sold
IncreaseDecreaseInDeferredCostOfGoodsSold
2177000 USD
CY2019 xbit Increase Decrease In Deferred Cost Of Goods Sold
IncreaseDecreaseInDeferredCostOfGoodsSold
-0 USD
CY2021 xbit Amount Held In Escrow
AmountHeldInEscrow
75063000 USD
CY2020 xbit Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
90000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1087000 USD
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
472000 USD
CY2020 xbit Amount Held In Escrow
AmountHeldInEscrow
-63000 USD
CY2019 xbit Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
444000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-514000 USD
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
CY2021 xbit Subscription Receivable
SubscriptionReceivable
0 USD
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
149000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-383000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-477228000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-334000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
496000 USD
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
23000 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2829000 USD
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2888000 USD
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 USD
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4500000 USD
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
4500000 USD
CY2021 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
0 USD
CY2020 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
0 USD
CY2019 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-3000 USD
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
212000 USD
CY2020 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
65000 USD
CY2019 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1056000 USD
CY2021 xbit Increase Decrease In Deferred Tax Liability
IncreaseDecreaseInDeferredTaxLiability
873000 USD
CY2020 xbit Increase Decrease In Deferred Tax Liability
IncreaseDecreaseInDeferredTaxLiability
-49219000 USD
CY2019 xbit Increase Decrease In Deferred Tax Liability
IncreaseDecreaseInDeferredTaxLiability
49361000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
69445000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-65149000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18270000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3525000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3727000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
204000 USD
CY2021 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2020 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2019 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
675000000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3525000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3727000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
674796000 USD
CY2021 xbit Proceeds From Payments For Repurchase Of Common Stock And Warrants Net
ProceedsFromPaymentsForRepurchaseOfCommonStockAndWarrantsNet
0 USD
CY2020 xbit Proceeds From Payments For Repurchase Of Common Stock And Warrants Net
ProceedsFromPaymentsForRepurchaseOfCommonStockAndWarrantsNet
-420000000 USD
CY2019 xbit Proceeds From Payments For Repurchase Of Common Stock And Warrants Net
ProceedsFromPaymentsForRepurchaseOfCommonStockAndWarrantsNet
38062000 USD
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
75003000 USD
CY2020 us-gaap Payments Of Dividends
PaymentsOfDividends
-0 USD
CY2019 us-gaap Payments Of Dividends
PaymentsOfDividends
-0 USD
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
7995000 USD
CY2020 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
10276000 USD
CY2019 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3732000 USD
CY2021 xbit Proceeds From Subscription Receivable
ProceedsFromSubscriptionReceivable
0 USD
CY2020 xbit Proceeds From Subscription Receivable
ProceedsFromSubscriptionReceivable
0 USD
CY2019 xbit Proceeds From Subscription Receivable
ProceedsFromSubscriptionReceivable
302000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-67008000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-409724000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
42096000 USD
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
705000 USD
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1372000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
698771000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
237366000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
714594000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15823000 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
809500
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
236983000 USD
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
676000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
237366000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
714594000 USD
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
93000 USD
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
8400000 USD
CY2020 xbit Subscription Receivable
SubscriptionReceivable
0 USD
CY2019 xbit Subscription Receivable
SubscriptionReceivable
302000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4656677
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
131874
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M7D
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
54087000 USD
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
237000000.0 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Use of Estimates </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The preparation of financial statements in accordance with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported values of amounts in the financial statements and accompanying notes. Actual results could differ from those estimates.</p>
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4464000 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12581000 USD
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3358000 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.29
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.23
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.36
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Concentrations of Credit Risk </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents. The Company holds these investments in highly-rated financial institutions, and limits the amounts of credit exposure to any <em style="font: inherit;">one</em> financial institution. These amounts at times <em style="font: inherit;"> may </em>exceed federally insured limits. The Company has <em style="font: inherit;">not</em> experienced any credit losses in such accounts and does <em style="font: inherit;">not</em> believe it is exposed to any significant credit risk on these funds. The Company has <em style="font: inherit;">no</em> off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts or other hedging arrangements.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1800000
CY2019 xbit Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercises In Period Net
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisesInPeriodNet
771376
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
361833
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10300000 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
84042
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5327425
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15731000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13111000 USD
CY2021Q4 xbit Property Plant And Equipment Including Building Construction In Process
PropertyPlantAndEquipmentIncludingBuildingConstructionInProcess
28308000 USD
CY2020Q4 xbit Property Plant And Equipment Including Building Construction In Process
PropertyPlantAndEquipmentIncludingBuildingConstructionInProcess
27336000 USD
CY2021 us-gaap Depreciation
Depreciation
2600000 USD
CY2020 us-gaap Depreciation
Depreciation
2200000 USD
CY2019 us-gaap Depreciation
Depreciation
2400000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
480000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
443000 USD
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
163000 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
174000 USD
CY2021Q4 xbit Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
618000 USD
CY2020Q4 xbit Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
497000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
113000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
237000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1374000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1351000 USD
CY2020Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
420000000.0 USD
CY2020Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
14000000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 xbit Stock Repurchased During Period Price Per Share
StockRepurchasedDuringPeriodPricePerShare
30
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
420000000.0 USD
CY2020Q1 xbit Percentage Of Outstanding Shares Repurchased
PercentageOfOutstandingSharesRepurchased
0.3267 pure
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1100000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8000000.0 USD
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5535439
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2563500
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3500000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.21
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y10M17D
CY2021 xbit Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercises In Period Net
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisesInPeriodNet
1348374
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M28D
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
230500
CY2020 xbit Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercises In Period Net
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisesInPeriodNet
1784763
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6965730
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
49837000 USD
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1806000 USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-9486000 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-1821000 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
48031000 USD
CY2021 xbit Current Other Tax Expense Benefit
CurrentOtherTaxExpenseBenefit
14000 USD
CY2020 xbit Current Other Tax Expense Benefit
CurrentOtherTaxExpenseBenefit
0 USD
CY2019 xbit Current Other Tax Expense Benefit
CurrentOtherTaxExpenseBenefit
0 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-17414000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-11221000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
668629000 USD
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30043380
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30823458
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38945468
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
17.17
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30043380
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30823458
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46319457
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
14.44
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4656677
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5327425
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6965730
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25458000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12827000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
718453000 USD
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
17000 USD
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
262000 USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-9455000 USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-1559000 USD
CY2021 xbit Effective Income Tax Rate Reconciliation Stock Compensation And Other Percent
EffectiveIncomeTaxRateReconciliationStockCompensationAndOtherPercent
-0.007 pure
CY2020 xbit Effective Income Tax Rate Reconciliation Stock Compensation And Other Percent
EffectiveIncomeTaxRateReconciliationStockCompensationAndOtherPercent
-0.069 pure
CY2019 xbit Effective Income Tax Rate Reconciliation Stock Compensation And Other Percent
EffectiveIncomeTaxRateReconciliationStockCompensationAndOtherPercent
-0.006 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.316 pure
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.125 pure
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.069 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
-0.077 pure
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
0.002 pure
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 USD
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1505000 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-155000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-13000 USD
CY2021 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-94000 USD
CY2020 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
108000 USD
CY2019 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
0 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1411000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-47000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-13000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1606000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49824000 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.270 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.270 pure
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.270 pure
CY2021 xbit Effective Income Tax Rate Reconciliation Capital Gain Exclusion Percent
EffectiveIncomeTaxRateReconciliationCapitalGainExclusionPercent
0.000 pure
CY2020 xbit Effective Income Tax Rate Reconciliation Capital Gain Exclusion Percent
EffectiveIncomeTaxRateReconciliationCapitalGainExclusionPercent
0.012 pure
CY2019 xbit Effective Income Tax Rate Reconciliation Capital Gain Exclusion Percent
EffectiveIncomeTaxRateReconciliationCapitalGainExclusionPercent
-0.130 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.041 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.373 pure
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.063 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.016 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.345 pure
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.011 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.017 pure
CY2019 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.004 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
-0.015 pure
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
955000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
752000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
873000 USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
533000 USD
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1100000 USD
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
4800000 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0 USD
CY2021Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
10700000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
112000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
60000 USD
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
3360000 USD
CY2020Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
3020000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3235000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4036000 USD
CY2021Q4 xbit Deferred Tax Assets Share Issuance Costs
DeferredTaxAssetsShareIssuanceCosts
425000 USD
CY2020Q4 xbit Deferred Tax Assets Share Issuance Costs
DeferredTaxAssetsShareIssuanceCosts
610000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
227000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
194000 USD
CY2021Q4 us-gaap Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
206000 USD
CY2020Q4 us-gaap Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
950000 USD
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
7565000 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8870000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6474000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7585000 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1091000 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1285000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
824000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
592000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
69000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
52000 USD
CY2021Q4 xbit Deferred Tax Liabilities Uncollectible Debts
DeferredTaxLiabilitiesUncollectibleDebts
1057000 USD
CY2020Q4 xbit Deferred Tax Liabilities Uncollectible Debts
DeferredTaxLiabilitiesUncollectibleDebts
0 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Unrealized Currency Transaction Gains
DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains
14000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Unrealized Currency Transaction Gains
DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains
108000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1964000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2060000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1056000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
42000 USD
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
49000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
0 USD
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
0 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
0 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
46000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
287000 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
1010000 USD
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0 USD
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0 USD
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
56000 USD
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
27000 USD
CY2019 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
2400000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
2100000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2389000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2060000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1056000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1100000 USD
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3553000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-10605000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3731000 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-7193000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2568000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-5118000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3261000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-6467000 USD
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2021Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2171000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6514000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4670000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4922000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-14000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-6844000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2526000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-1838000 USD

Files In Submission

Name View Source Status
0001171843-22-001904-index-headers.html Edgar Link pending
0001171843-22-001904-index.html Edgar Link pending
0001171843-22-001904.txt Edgar Link pending
0001171843-22-001904-xbrl.zip Edgar Link pending
ex_345369.htm Edgar Link pending
ex_345370.htm Edgar Link pending
ex_345371.htm Edgar Link pending
ex_345375.htm Edgar Link pending
ex_345380.htm Edgar Link pending
ex_345381.htm Edgar Link pending
ex_345538.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pipe.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xbit-20211231.xsd Edgar Link pending
xbit-20211231_cal.xml Edgar Link unprocessable
xbit-20211231_def.xml Edgar Link unprocessable
xbit-20211231_lab.xml Edgar Link unprocessable
xbit-20211231_pre.xml Edgar Link unprocessable
xbit20211231_10k.htm Edgar Link pending
xbit20211231_10k_htm.xml Edgar Link completed